Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
86
days
Progress with FAK inhibitors in the patent literature (2020-present)
Authors
Bing-Bing Chen; Rui-Peng Feng; Jin-Bo Niu; Jian Song; Yuan-Bo Cui; Sai-Yang ZhangShow moreShow less
Affiliations
1. Zhengzhou University; 2. The Third Affiliated Hospital of Zhengzhou University; 3. Zhengzhou Central Hospital Affiliated to Zhengzhou UniversityShow moreShow less
78
days
Selective PARP1 inhibitors (2021–2025): patent landscape, structural evolution, and future therapeutic opportunities
Authors
Jilong Duan; Yanjing Duan; Dongling Gu; Jia Yang; Fenghua Kang; Youchao Deng; Dongsheng CaoShow moreShow less
Affiliations
1. Central South University; 2. Hong Kong Baptist UniversityShow moreShow less
120
days
An updated patent review of STAT6 inhibitors and modulators (2020 – present)
Authors
Muhammad Zafar Irshad Khan; Bo-Qun Du; Mei Xue; Meng-Qian Yu; Shun-Ran Li; Jianshe Wang; Chen-Chen Wang; Xiang-Yang YeShow moreShow less
Affiliations
1. Hangzhou Normal University; 2. Hangzhou Purple Crystal PharmaShow moreShow less
79
days
Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure–activity relationships and patent coverage
Authors
Christian Gege; Gerald KleymannShow moreShow less
Affiliations
1. Innovative Molecules GmbHShow moreShow less
140
days
T-type calcium channel blockers: a review of recent advances (2018–2025)
Authors
Yasinalli Tamboli; Laurent Ferron; Gerald W. ZamponiShow moreShow less
Affiliations
1. King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs (MNGH); 2. University of CalgaryShow moreShow less
63
days
Myeloperoxidase (MPO) inhibitors: an updated patent review (2020 - present)
Authors
Zhiwei Meng; Dan Chen; Xingyu Yao; Feng Wang; Zhouling XieShow moreShow less
Affiliations
1. Hefei University of TechnologyShow moreShow less
FAQ
How long does EXPERT OPINION ON THERAPEUTIC PATENTS take to review a manuscript?
As of 2026-11-19, CrushSCI has 14 complete review records for EXPERT OPINION ON THERAPEUTIC PATENTS. The fastest paper went from submission to acceptance in 63 days (Myeloperoxidase (MPO) inhibitors: an updated patent review (2020 - present), received 2026-05-21, accepted 2026-07-23); the slowest took 149 days. The average is 96.4 days and the median is 88 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
